PBL Logo - click here to return to homepage spacer


Biomarkers can provide information on the different physiological pathways involved in disease progression and hence can be used to measure the safety and efficacy of the drug for a specific disease indication. Often, biomarkers are primary or secondary endpoints in clinical trials.

The bioanalytical laboratory at Pacific BioLabs can develop and validate methods to analyze biomarkers in preclinical and clinical samples such as plasma, serum, urine, tissue, and CSF. Over the past 20 years, we have performed bioanalytical method development for different biomarkers such as proteins, peptides and carbohydrates using LC/MS/MS, ELISA and activity assays. We specialize in ELISA method development and LC/MS method development.

Biomarker Analytical Techniques Available

  • Method Development and Validation
  • Analysis to Support Preclinical and Clinical Development
  • ELISA and Activity Assays
  • LC/MS/MS
  • Instrumentation Details

Biomarker Related Testing

Biomarker Testing Standards

Read More About Biomarker Analysis


Intertek Logo PBL is FDA registered and ISO 9001:2008 and ISO 13485:2003 certified by Intertek. AAALAC Logo Our animal science operations are accredited by AAALAC.

Request a quote Send an email